707 million middle class, in 2018 They're doin ok. They can...

First 248 Last

Share
Profile

Follow
Howard Ino

12,006 Posts.

669

24/07/24

19:47

Post #: 74900895
Share

Originally posted by Phantom77 ↑

feel sorry for all those holders of agy who listened to the up rampers on HC.

cheapest producer blah blah blah.

they produced but had no buyers. Only recently did they announced an offtake agreement.

now mine is in care taker mode.

Just like other dreamers on cxo.....takeover....too small.
stop dreaming ..... be more realistic ..... and stop reading the uprampers on here.....

Only efficient producer is LTM and surviving is PLS.

Even, these 2 stocks, i hope they can survive the low Li price for a few years to come.

As long as jhina property debt crisis has not been resolved, Li price will continue to drift lower. And the latest news, is that jhina cannot find a solution nor the right policy to ease the debt crisis, which on my estimate affects between 300m to 450m pple.

imagine 450m pple out of debt in jhina and buying EVs..... So the only number you need to track is jhina property debt and the number of pple affected. The more property the govt can help complete, the faster the eco can start growing again and more pple can sale out from their debt and the quicker Li price will pick up.
The western world and the rest of world is not taking up EVs as quickly and to the same amount as jhina.

Expand

707 million middle class, in 2018
They're doin ok.
They can afford a new EV or two...

AGY Price at posting: 4.9¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 257 more messages in this thread...

First 248 Last

Add AGY (ASX) to my watchlist

(20min delay)
Last 3.9¢		Change 0.001(2.63%)		Mkt cap ! $58.23M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.9¢	$113.7K	2.916M

Buyers (Bids)

No.	Vol.	Price($)
7	923298	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.9¢	191096	3

View Market Depth

No.	Vol.	Price($)
6	898298	0.038
7	1065851	0.037
24	2492708	0.036
29	2807561	0.035
6	1226910	0.034

Price($)	Vol.	No.
0.039	191096	3
0.040	994722	8
0.041	675788	7
0.042	1003264	11
0.043	1582232	4

Last trade - 11.14am 04/10/2024 (20 minute delay)

AGY (ASX) Chart

707 million middle class, in 2018 They're doin ok. They can...

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

707 million middle class, in 2018 They're doin ok. They can...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News